Navigation Links
Protein snapshots reveal clues to breast cancer outcomes
Date:5/5/2011

Measuring the transfer of tiny amounts of energy from one protein to another on breast cancer cells has given scientists a detailed view of molecular interactions that could help predict how breast cancer patients will respond to particular therapies.

At the IMPAKT Breast Cancer Conference in Brussels, Dr Gargi Patel from the Richard Dimbleby Department, King's College London, described cutting-edge research in which she and colleagues captured detailed information about protein interactions on cancer cells, and correlated that with established genetic markers for cancer spread.

Dr Patel's group used a microscope technique known as Foerster resonance energy transfer (FRET) imaging, which allows them to measure the interactions between two proteins.

In this technique, each of the proteins is labeled with a fluorescent tag --one might be labeled green and the other red, for example. A laser is used to excite one of these labels, which becomes excited and then decays back to its rest state in a specific lifetime, which the researchers define as its fluorescent lifetime.

When this label comes within a nanometer of the second label, exciting by the laser causes some of its energy to be donated to the other label, and the fluorescent lifetime of the first label becomes shorter. "In the context of our work, this process only occurs when two proteins are close enough to be interacting, and hence we can quantitate protein-protein interactions," Dr Patel explains.

In earlier work, Dr Patel's group used this technique on breast cancer cells in the lab to describe in detail the interaction between the cell-surface molecules Her2 and Her3 that is known to determine whether a cancer will respond to the drug lapatinib.

"We aim to establish a 'signature' representing functional molecular biology, by examining protein-protein interactions, and to correlate this signature with established prognostic gene signatures and clinical and radiological data to predict patient outcome in terms of likelihood of recurrence and response to treatment such as lapatinib," Dr Patel explains. "The results we present at IMPAKT are the start of this work."

"The work I am doing captures images of the molecular state of Her2-Her3 receptors as a dimer, and shows us the results of lapatinib treatment. We have also identified a specific mutation in Her2, which reduces dimerization and the lapatinib effect. We can test tumor samples for this Her2 mutation, which would confer resistance to treatment."

This technology could have a significant clinical impact, the researchers say, by improving the accuracy of predictions about a cancer's risk of spread or response to treatment.

"Currently our methods of prognosis estimation depend on clinical data such as tumor size and lymph node status, or upon correlation with genetic signatures which may delineate tumors with higher metastatic potential. However the accuracy of any single method is far from 100%. We aim to add to the tools available by introducing a signature reflecting the functional state of cancer cells, by assessing protein-protein interactions. We could integrate this information with genetic and clinical data to more accurately predict outcome," Dr Patel said.

Commenting on the study, which he was not involved in, Dr Stephen Johnston, from Royal Marsden NHS Foundation Trust & Institute of Cancer Research, noted: "Lapatinib is a novel drug to target Her2 positive breast cancer, and works in a different way to the established monoclonal antibody trastuzumab."

"It is recognized that other growth factor receptors in breast cancer such as Her3 can modulate how Her2 positive tumors respond, often making them resistant to trastuzumab. In contrast, these researchers have developed as assay to measure Her2/Her3 heterodimers and the molecular pathways that they activate in human tumors, and suggest that in future this assay could be used to predict for response to lapatinib in the clinic."


'/>"/>

Contact: Vanessa Pavinato
media@esmo.org
European Society for Medical Oncology
Source:Eurekalert

Related medicine news :

1. New and Delicious, Almond Butter Filled, Cookie Bites With 35.7% Protein to Help Manage Weight and Build Muscle
2. Research highlights role of protein pair in obesity regulation
3. Urine protein test might help diagnose kidney damage from lupus, UT Southwestern researchers find
4. Smithfield, United Food and Commercial Workers Union, and Food Networks Paula Deen to Deliver 150,000 Servings of Protein to San Francisco Food Bank
5. Protein Sciences Corporation Announces Profitable and Cash Flow Positive Results for 2009 and Management Realignment
6. Protein Appears Key to Intestinal Balance
7. SIBLING proteins may predict oral cancer
8. Damaged protein identified as early diagnostic biomarker for Alzheimers disease in healthy adults
9. Cells of aggressive leukemia hijack normal protein to grow
10. Omega Protein Comments on California Lawsuit Alleging Fish Oil Contaminants
11. Proteins May Predict Spread of Colon Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... , ... SuperCloset is proud to officially launch our “Helping Veterans Grow ... and obstacles veterans’ need to overcome in order to face their life changes upon ... veteran(s) with a donated SuperCloset product based on the needs and ability of helping ...
(Date:5/28/2016)... AL (PRWEB) , ... May 28, 2016 , ... May ... US Open Martial Arts Fighting Challenge with theme event of “K Warriors” on June ... Mobile, AL 36608. , The event is sponsored and hosted by Shaolin Institute ...
(Date:5/28/2016)... ... ... a part of the city where’s it’s easy to spot the neon lights of chains ... to attract diners with a taste for real food. , On May 13, the ... Grill, an urban casual restaurant focusing on dishes made by hand with wholesome, organic ingredients ...
(Date:5/27/2016)... SC (PRWEB) , ... May 27, 2016 , ... ... a line of classic American timber frame barn kits, which can be found on ... are inspired by historic American barn plans, and they highlight the craftsmanship of timber ...
(Date:5/27/2016)... ... May 27, 2016 , ... W.S. Badger Co. Inc ., ... it has been recognized as one of the best small businesses for new dads ... one of nine small businesses providing progressive benefits to new parents on the organization’s ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... NEW YORK , May 25, 2016 ... Device Market Size, Share, Development, Growth and Demand Forecast ... Insulin Syringe, Insulin Pump and Others)" published by P&S ... valued at $9,998.3 million in 2015, and it is ... 2016-2022. Based on type, the insulin pump segment is ...
(Date:5/25/2016)... -- MedDay, a biotechnology company focused on the ... entitled "High doses of biotin in progressive multiple sclerosis: extension ... Professor Ayman Tourbah , Principal Investigator of the Phase ... of Neurology (EAN) in Copenhagen, Denmark . ... place on Sunday, 29 May 2016 from 14:45 to 16:15 ...
(Date:5/24/2016)... May 24, 2016 Cirujanos holandeses ... ayudar a los médicos a compartir sus mejores prácticas ... escala mundial. Profesionales médicos de Europa, África, ... apuntado a la aplicación, que combina la transmisión en ... totalmente seguro. Educación   "Imagine un ...
Breaking Medicine Technology: